IDWeek 2018

The efficacy of omadacycline was demonstrated in Gram-positive and Gram-negative clinical isolates from 3 completed phase 3 trials involving tetracycline nonsusceptible pathogens.
When considering antibiotic-prescribing guidelines in the community setting, is “one size fits all” applicable in the face of emerging extended-spectrum cephalosporin-resistant Enterobacteriaceae?
Investigators evaluated the in vitro activity of omadacycline, a novel aminomethylcycline antibiotic, against a collection of clinical isolates resistant to other available tetracyclines.
Page 3 of 3
Results 21 - 23 of 23
  •  Association for Value-Based Cancer Care
  • Oncology Practice Management
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Rheumatology Practice Management
  • Urology Practice Management
  • Lynx CME